40.94
price down icon0.55%   -0.2324
 
loading

Finanzdaten der Exelixis Inc-Aktie (EXEL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-10-03 2025-07-04 2025-04-04 2024-09-27 2024-06-28
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
5.19%
597.75
568.26 555.45 539.54 637.18
Cost Of Revenue
4.60%
18.57
19.47 19.17 17.33 17.67
Gross Profit
5.54%
579.18
548.79 536.27 522.21 619.51
Operating Expenses
2.22%
342.64
335.21 349.42 386.14 343.64
Benefits Costs and Expenses
1.84%
361.21
354.69 368.59 403.47 361.30
Costs And Expenses
1.84%
361.21
354.69 368.59 403.47 361.30
Operating Income/Loss
10.75%
236.54
213.58 186.86 136.07 275.87
Income/Loss From Continuing Operations Before Tax
10.75%
236.54
213.58 186.86 136.07 275.87
Income Tax Expense/Benefit
29.12%
58.84
45.57 46.07 36.78 66.73
Income/Loss From Continuing Operations After Tax
4.72%
193.58
184.85 159.62 117.97 226.12
Net Income/Loss
4.72%
193.58
184.85 159.62 117.97 226.12
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.53%
268.42
272.58 278.80 285.62 289.22
Diluted Average Shares
2.06%
278.54
284.39 288.18 291.48 293.97
Basic Earnings Per Share
5.88%
0.72
0.68 0.57 0.41 0.78
Diluted Earnings Per Share
6.15%
0.69
0.65 0.55 0.40 0.77
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):